Published in
Taylor and Francis Group, Expert Opinion on Drug Safety, 7(15), p. 983-991, 2016
DOI: 10.1080/14740338.2016.1186639
Links
Tools
Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation
Journal article published in 2016 by
Francesca Romana Ponziani,
Silvia Pecere,
Loris Lopetuso,
Franco Scaldaferri 
,
Giovanni Cammarota,
Antonio Gasbarrini
,
Giovanni Cammarota,
Antonio Gasbarrini
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 